TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2180271

Group type: COMPARATOR
Intervention: Cisplatin 100 mg/m2 alone (group I)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Cisplatin 100 mg/m2 and oral disulfiram 2000 mg/m2 (group II)
Number of subjects: 53
Study: 453982

Group type: EXPERIMENTAL
Intervention: Intrathoracic intercostal block with bupivacaine
Number of subjects: 0
Study: 31069935

Group type: EXPERIMENTAL
Intervention: Faster aspart (0.3 U/kg)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Insulin aspart (IAsp) (0.3 U/kg)
Number of subjects: 61
Study: 29250529

Group type: EXPERIMENTAL
Intervention: COPD‐GRIP intervention (nurse-led illness perception intervention)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 204
Study: 26502953

Group type: EXPERIMENTAL
Intervention: Rhodiola rosea L (2 × 200 mg dose Vitano®, 1 tablet taken before breakfast and 1 tablet before lunch)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control condition (no treatment)
Number of subjects: 80
Study: 25603659

Group type: EXPERIMENTAL
Intervention: Off pump CABG (group-B)
Number of subjects: 200

Group type: COMPARATOR
Intervention: On pump CABG (group-A)
Number of subjects: 200
Study: 21094048

Group type: EXPERIMENTAL
Intervention: Skill focused instruction
Number of subjects: 18

Group type: COMPARATOR
Intervention: No instruction
Number of subjects: 18
Study: 20028190

Group type: EXPERIMENTAL
Intervention: Online, video-based education
Number of subjects: 78

Group type: COMPARATOR
Intervention: Written educational material (pamphlet)
Number of subjects: 78
Study: 17310505

Group type: EXPERIMENTAL
Intervention: Gastric banding surgery
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal weight control group
Number of subjects: 50
Study: 15380963

Group type: EXPERIMENTAL
Intervention: Invasive treatment (angiography and intervention within 24 hours of thrombolysis)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Conservative approach (ischaemia-guided)
Number of subjects: 500
Study: 12511208

Group type: EXPERIMENTAL
Intervention: Dyad Intervention (DI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caregiver Intervention (CI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait List Control (WLC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dyad Intervention (DI) for care-recipients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caregiver Intervention (CI) for care-recipients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait List Control (WLC) for care-recipients
Number of subjects: 0
Study: 9694317

Group type: EXPERIMENTAL
Intervention: Interval training at ventilatory threshold (Vth), walking/jogging sessions twice a week, duration increased from 30 min to 1 h over 3 months
Number of subjects: 22
Study: 8589465

Group type: EXPERIMENTAL
Intervention: 10% low molecular weight dextran at 25 mL/hr
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 19
Study: 2760258

Group type: EXPERIMENTAL
Intervention: Norfloxacin (NOR) 800 mg/d
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (C) 1 g/d
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Nalidixic acid (NAL) 2 g/d
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 8
Study: 62613

Group type: EXPERIMENTAL
Intervention: BACON plus BCG
Number of subjects: 34

Group type: COMPARATOR
Intervention: BACON
Number of subjects: 34
Study: 29796671

Group type: EXPERIMENTAL
Intervention: Monosodium glutamate (MSG) supplemented vegetable broth (3.8 g MSG daily for 4 weeks)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Sodium-matched broth without MSG (control)
Number of subjects: 58
Study: 28370134

Group type: EXPERIMENTAL
Intervention: FLEXITHERALIGHT protocol (fractionated irradiation with 12.3 mW/cm2 after 30 minutes incubation time)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard protocol (continuous irradiation with 75 mW/cm2 after 3 hours incubation time)
Number of subjects: 0
Study: 26180109

Group type: EXPERIMENTAL
Intervention: Technosphere insulin (TI)
Number of subjects: 345

Group type: COMPARATOR
Intervention: Insulin aspart (C)
Number of subjects: 345
Study: 22181827

Group type: EXPERIMENTAL
Intervention: QS ruby laser, aggressive treatment (Group 1)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: QS ruby laser, mild treatment (Group 2)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: QS frequency doubled Nd:YAG laser, aggressive treatment (Group 3)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: QS frequency doubled Nd:YAG laser, mild treatment (Group 4)
Number of subjects: 193
Study: 20962614

Group type: EXPERIMENTAL
Intervention: Interferon‐α administration during structured treatment interruptions (STIs)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Control group (without α‐interferon)
Number of subjects: 168
Study: 18788026

Group type: EXPERIMENTAL
Intervention: Emotional faces (sad, happy, fearful)
Number of subjects: 21
Study: 17459295

Group type: EXPERIMENTAL
Intervention: Topical diflucortolone valerate 0.001 percent and oral cetirizine hydrochloride (Group A)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Oral ciprofloxacin in addition to topical diflucortolone valerate and oral cetirizine hydrochloride (Group B)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Oral prednisolone or intralesional triamcinolone acetonide (for severe cases)
Number of subjects: 50
Study: 12729776

Group type: EXPERIMENTAL
Intervention: Prelaminated fasciomucosal flaps
Number of subjects: 32

Group type: COMPARATOR
Intervention: Non-prelaminated fasciocutaneous flaps
Number of subjects: 32
Study: 10937329

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 8927677

Group type: EXPERIMENTAL
Intervention: Nicotine (7 mg/day for nonsmokers and 21 mg/day for smokers)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 1642023

Group type: EXPERIMENTAL
Intervention: Diet and/or oral antidiabetics
Number of subjects: 751

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 751
Study: 6403965

Group type: EXPERIMENTAL
Intervention: Chlorpromazine (CPZ)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Promazine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control experiments
Number of subjects: 0
Study: 31462460

Group type: EXPERIMENTAL
Intervention: Heart failure with stroke
Number of subjects: 1023
Study: 29364357

Group type: EXPERIMENTAL
Intervention: Web-based intervention providing normative feedback on alcohol consumption, risks, and tips to reduce damage.
Number of subjects: 465

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 465
Study: 28219056

Group type: EXPERIMENTAL
Intervention: 927 ppm F/5% CSPS
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: 0 ppm F/5% CSPS
Number of subjects: 77

Group type: COMPARATOR
Intervention: 927 ppm F/0% CSPS
Number of subjects: 77

Group type: COMPARATOR
Intervention: 0 ppm F/0% CSPS
Number of subjects: 77
Study: 26156248

Group type: EXPERIMENTAL
Intervention: Fecal Occult Blood Testing (FOBT)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Optical Colonoscopy (OC)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Virtual Colonoscopy (VC)
Number of subjects: 198
Study: 23526980

Group type: EXPERIMENTAL
Intervention: Upper quartile of baseline WBC counts
Number of subjects: 1637

Group type: EXPERIMENTAL
Intervention: Top quartile of leukocyte count
Number of subjects: 1637

Group type: EXPERIMENTAL
Intervention: Top quartile of neutrophil count
Number of subjects: 1637

Group type: EXPERIMENTAL
Intervention: Top quartile of lymphocyte count
Number of subjects: 1637

Group type: EXPERIMENTAL
Intervention: Increase in total WBC during follow-up
Number of subjects: 1637

Group type: EXPERIMENTAL
Intervention: Leukocyte and neutrophil count
Number of subjects: 1637

Group type: EXPERIMENTAL
Intervention: Lymphocyte counts
Number of subjects: 1637
Study: 21173348

Group type: EXPERIMENTAL
Intervention: Final Kissing Balloon Dilatation (FKBD)
Number of subjects: 477

Group type: COMPARATOR
Intervention: No Final Kissing Balloon Dilatation (no FKBD)
Number of subjects: 477
Study: 18489412

Group type: EXPERIMENTAL
Intervention: Mother-baby intervention (8-10 home visits)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Parenting support by telephone (control group)
Number of subjects: 71
Study: 17137597

Group type: EXPERIMENTAL
Intervention: Computer-based respiratory safety training with text, pictures, and audio narration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Computer-based respiratory safety training (general)
Number of subjects: 0
Study: 14624375

Group type: EXPERIMENTAL
Intervention: PEG‐IFN alone or combined with ribavirin (RBV)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard IFN plus RBV
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: PEG‐IFN or IFN
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: HCV treatment
Number of subjects: 10
Study: 11113401

Group type: EXPERIMENTAL
Intervention: Pravastatin (combined with cholestyramine and/or nicotinic acid) to achieve LDL cholesterol levels of < or =130 mg/dl (group A)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control group (group B) with antilipidemic therapy determined by family physicians
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Pravastatin-based therapy (group A)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control group (group B)
Number of subjects: 126
Study: 8702032

Group type: EXPERIMENTAL
Intervention: Chloroquine regimen
Number of subjects: 4127

Group type: EXPERIMENTAL
Intervention: Mefloquine regimen
Number of subjects: 4127

Group type: EXPERIMENTAL
Intervention: No prophylaxis before first antenatal clinic visit
Number of subjects: 4127

Group type: EXPERIMENTAL
Intervention: High transmission season
Number of subjects: 4127

Group type: EXPERIMENTAL
Intervention: Young age (< 20 years)
Number of subjects: 4127

Group type: EXPERIMENTAL
Intervention: Low hematocrit
Number of subjects: 4127

Group type: EXPERIMENTAL
Intervention: Short stature
Number of subjects: 4127

Group type: EXPERIMENTAL
Intervention: Second trimester (compared with third trimester)
Number of subjects: 4127
Study: 7703926

Group type: EXPERIMENTAL
Intervention: Early initiation of AmBisome
Number of subjects: 200

Group type: COMPARATOR
Intervention: Later use of AmBisome
Number of subjects: 200
Study: 3297472

Group type: EXPERIMENTAL
Intervention: Caffeine 360 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Caffeine >90 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Caffeine (dose-related)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Caffeine (not dose-related)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 8
Study: 31327670

Group type: EXPERIMENTAL
Intervention: Aerosolized 15% xylitol (5 ml) twice a day for 14 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Aerosolized 7% hypertonic saline (4 ml) twice a day for 14 days
Number of subjects: 60
Study: 29211295

Group type: EXPERIMENTAL
Intervention: IROX/Bev (for TS-H tumors)
Number of subjects: 247

Group type: COMPARATOR
Intervention: FOLFOX/Bev (for TS-H tumors)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: FOLFOX/Bev (for TS-L tumors)
Number of subjects: 247
Study: 27350298

Group type: EXPERIMENTAL
Intervention: STA-MCA anastomosis
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (conservative treatment)
Number of subjects: 30
Study: 25006069

Group type: EXPERIMENTAL
Intervention: Immunologically castrated (IC) barrows
Number of subjects: 47
Study: 23880340

Group type: EXPERIMENTAL
Intervention: Polydextrose (PDX) diet
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Soluble maize fibre (SCF) diet
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control diet (full energetic)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control diet (isoenergetic)
Number of subjects: 18
Study: 23163143

Group type: EXPERIMENTAL
Intervention: Comprehensive protocol of integrative medicine (naomai jiejing decoction No. 1 and No. 2)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Basic therapy and nimodipine (control group)
Number of subjects: 63
Study: 20577753

Group type: EXPERIMENTAL
Intervention: Piezosurgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Microdrill
Number of subjects: 60
Study: 18032857

Group type: EXPERIMENTAL
Intervention: Oral terbinafine 250 mg, one tablet twice daily for seven days every month (pulse therapy)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Oral terbinafine pulse therapy plus topical ciclopirox olamine 8% applied once daily at night
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Oral terbinafine pulse therapy plus topical amorolfine hydrochloride 5% applied once weekly at night
Number of subjects: 96
Study: 16151607

Group type: EXPERIMENTAL
Intervention: KTP 532-nm laser treatment with pulse duration (PD) varying from 0.13 to 1.71 times thermal relaxation time (Tr)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: KTP 532-nm laser treatment with PD near or higher than Tr
Number of subjects: 28
Study: 11967748

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2% with sufentanil 2 microgram/ml
Number of subjects: 40

Group type: COMPARATOR
Intervention: Bupivacaine 0.25% with sufentanil 2 microgram/ml
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 10402613

Group type: EXPERIMENTAL
Intervention: Didactic format patient education (N = 16)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Discussion of subjective experiences with schizophrenia (Control group, N = 17)
Number of subjects: 33
Study: 8649183

Group type: EXPERIMENTAL
Intervention: 50-Hz linearly polarized magnetic fields (10 mu T)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (sham-exposed)
Number of subjects: 32
Study: 1428294

Group type: EXPERIMENTAL
Intervention: Gallopamil 50 mg single-dose
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Gallopamil 50 mg steady-state (after nine doses)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 4069259

Group type: EXPERIMENTAL
Intervention: Laser evaporation
Number of subjects: 165

Group type: COMPARATOR
Intervention: Cryosurgery
Number of subjects: 165
Study: 30251577

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 30253807

Group type: EXPERIMENTAL
Intervention: Sensor-based feedback
Number of subjects: 54

Group type: COMPARATOR
Intervention: Feedback from a mirror
Number of subjects: 54

Group type: COMPARATOR
Intervention: No feedback (control group)
Number of subjects: 54
Study: 26490053

Group type: COMPARATOR
Intervention: No antibiotics (no-antibiotic group)
Number of subjects: 623

Group type: EXPERIMENTAL
Intervention: CT findings
Number of subjects: 623
Study: 25129631

Group type: EXPERIMENTAL
Intervention: Inflectional morphology elicitation in individuals with PPA
Number of subjects: 48

Group type: COMPARATOR
Intervention: Healthy age-matched controls
Number of subjects: 48
Study: 22923209

Group type: EXPERIMENTAL
Intervention: Multisensory temporal processing (simultaneity judgment task)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Self-reported symptoms of autism (Autism Spectrum Quotient questionnaire)
Number of subjects: 100
Study: 20102625

Group type: EXPERIMENTAL
Intervention: Rehabilitation programme
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Education booklet
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Rehabilitation programme plus education booklet
Number of subjects: 344

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 344
Study: 17664372

Group type: EXPERIMENTAL
Intervention: In-treatment LV hypertrophy absence (measured by CP and SLV)
Number of subjects: 9193

Group type: EXPERIMENTAL
Intervention: In-treatment LV hypertrophy absence (measured by SLV)
Number of subjects: 9193

Group type: EXPERIMENTAL
Intervention: In-treatment LV hypertrophy absence (measured by CP)
Number of subjects: 9193

Group type: EXPERIMENTAL
Intervention: Absence of in-treatment LV hypertrophy (by both SLV and CP)
Number of subjects: 9193
Study: 15618782

Group type: EXPERIMENTAL
Intervention: Endotracheal Tube (ETT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Laryngeal Mask Airway
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both ETT and Laryngeal Mask Airway
Number of subjects: 20
Study: 12239682

Group type: EXPERIMENTAL
Intervention: Optimal grip span for women
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Optimal grip span for men
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Mathematical equation for women
Number of subjects: 70
Study: 10847873

Group type: EXPERIMENTAL
Intervention: Mutual practice visits by peers
Number of subjects: 90

Group type: COMPARATOR
Intervention: Visits by non-physician observers
Number of subjects: 90
Study: 7802522

Group type: EXPERIMENTAL
Intervention: Foscarnet
Number of subjects: 234

Group type: COMPARATOR
Intervention: Ganciclovir
Number of subjects: 234
Study: 1564083

Group type: EXPERIMENTAL
Intervention: Lithium carbonate for a minimum of 8 weeks
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (in double blind crossover)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 11
Study: 6382987

Group type: EXPERIMENTAL
Intervention: Acebutolol (400 mg thrice daily)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg thrice daily)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Acebutolol
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 16
Study: 31166400

Group type: EXPERIMENTAL
Intervention: QMiX+MA
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: QMiX+PUI
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: EDTA+MA
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: EDTA+PUI
Number of subjects: 40
Study: 28789578

Group type: EXPERIMENTAL
Intervention: Accelerated intermittent theta‐burst stimulation (aiTBS) treatment over the left dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 50
Study: 27165185

Group type: EXPERIMENTAL
Intervention: Tailored work-related support consisting of three face-to-face meetings of approximately 30 minutes each, with support types A (oncological nurse), B (oncological occupational physician), or C (multidisciplinary team)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Usual care (psychosocial care without work-related discussions)
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Tailored work-related support
Number of subjects: 310

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 310
Study: 24533471

Group type: EXPERIMENTAL
Intervention: High-intensity physical education (2 classes, n = 39)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Low-to-moderate intensity physical education (1 class, n = 20)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Small-sided indoor soccer (SO)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Basketball (BB)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Unihockey (UH)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Circuit training (CT)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Walking (W)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Nintendo Wii Boxing (NWB)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Nintendo Wii Tennis (NWT)
Number of subjects: 93
Study: 22695239

Group type: EXPERIMENTAL
Intervention: Solabegron 125 mg
Number of subjects: 258

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 258
Study: 20056957

Group type: EXPERIMENTAL
Intervention: Gain-framed counseling
Number of subjects: 2032

Group type: COMPARATOR
Intervention: Standard-care counseling
Number of subjects: 2032
Study: 17515259

Group type: EXPERIMENTAL
Intervention: Carotid angioplasty and stenting (CAS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 0
Study: 15616847

Group type: EXPERIMENTAL
Intervention: Resistance training (S)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Endurance training (E)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Combined resistance and endurance training (SE)
Number of subjects: 31
Study: 12140402

Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005%
Number of subjects: 54
Study: 9987165

Group type: EXPERIMENTAL
Intervention: Diphtheria antitoxin (> 0.01 IU ml‐1)
Number of subjects: 5187

Group type: EXPERIMENTAL
Intervention: Age-related susceptibility
Number of subjects: 5187

Group type: EXPERIMENTAL
Intervention: Diphtheria antitoxin levels
Number of subjects: 5187
Study: 7567643

Group type: EXPERIMENTAL
Intervention: Lactitol (250-400 mg/kg/day)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Lactulose (500-750 mg/kg/day)
Number of subjects: 51
Study: 2187272

Group type: EXPERIMENTAL
Intervention: 1.5 litre regimen supplemented with bisacodyl
Number of subjects: 32

Group type: COMPARATOR
Intervention: 4 litre regimen of a solution of electrolytes and polyethylenglycol
Number of subjects: 32
Study: 665565

Group type: EXPERIMENTAL
Intervention: High fiber diet containing fruits and vegetables
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low fiber diet containing fruit and vegetable juices
Number of subjects: 12
Study: 31455295

Group type: EXPERIMENTAL
Intervention: Remifentanil 0.3 μg/kg (diluted to 2 ml) 1 min before sufentanil injection
Number of subjects: 84

Group type: COMPARATOR
Intervention: Normal saline (NS) 2 ml at the same time point as sufentanil injection
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Remifentanil 0.3 μg/kg
Number of subjects: 84

Group type: COMPARATOR
Intervention: Normal saline (NS)
Number of subjects: 84
Study: 28984746

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 44

Group type: COMPARATOR
Intervention: Perphenazine
Number of subjects: 44
Study: 25940230

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with extra-virgin olive oil (EVOO)
Number of subjects: 7447

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with nuts
Number of subjects: 7447

Group type: COMPARATOR
Intervention: Control diet (advice on a low-fat diet)
Number of subjects: 7447
Study: 23584080

Group type: EXPERIMENTAL
Intervention: Gait speed
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Walking distance
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Gait speed adjusted for confounding
Number of subjects: 241
Study: 20889287

Group type: EXPERIMENTAL
Intervention: Mild hypothermia therapy (body temperature maintained at 32.7°C for 72 hours)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Mild hypothermia therapy
Number of subjects: 81

Group type: COMPARATOR
Intervention: Normothermia
Number of subjects: 81